Characterization and Treatment of Chemotherapy Neuropathy

NACompletedINTERVENTIONAL
Enrollment

754

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 8, 2015

Study Completion Date

December 8, 2015

Conditions
Chemotherapy-induced Neuropathy
Interventions
PROCEDURE

Photon stimulation

The LED diode wavelength chosen for this study is 870 nanometers. When activated, the photon stimulator is preset to deliver 1800 Joules in a 7 minute treatment period. Patients will receive a total of 8 treatments, to both feet simultaneously, within a 14 day period depending on their schedule.

PROCEDURE

Placebo treatment

"For patients who receive the placebo treatment, the electronic control unit will be deactivated (i.e., no energy is delivered) even though the indicator lights will be illuminated when the power switch is turned to the ON position. Using this procedure, the research nurse who administers the treatments and collects the outcome data will be blinded to the patients' group assignment."

Trial Locations (1)

94143

University of California, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01557608 - Characterization and Treatment of Chemotherapy Neuropathy | Biotech Hunter | Biotech Hunter